Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thalidomide and Lenalidomide for Refractory Systemic/Cutaneous Lupus Erythematosus Treatment

Published:2019-11-06 Issue:6 Volume:27 Page:248-259
ISSN:1536-7355
Container-title:JCR: Journal of Clinical Rheumatology
language:en
Short-container-title:J Clin Rheumatol

Author:

Yuki Emily Figueiredo Neves,Silva Clovis A.,Aikawa Nadia E.,Romiti Ricardo,Heise Carlos Otto,Bonfa Eloisa,Pasoto Sandra Gofinet

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Rheumatology

Reference101 articles.

1. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome;Br J Dermatol,2012

2. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus;Lupus,1997

3. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark;Lupus,2018

4. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States;Arthritis Care Res (Hoboken),2015

5. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden;Lupus,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII;Lupus;2024-08-08

2. Thalidomide for management of refractory oral mucosal diseases;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-04

3. Cytotoxic Programming of CD4+ T Cells Is Regulated by Opposing Actions of the Related Transcription Factors Eos and Aiolos;The Journal of Immunology;2024-02-16

4. Dermatology images: Lupus erythematosus;Journal of the American Academy of Dermatology;2023-10

5. Thalidomide Alleviates Apoptosis, Oxidative Damage and Inflammation Induced by Pemphigus Vulgaris IgG in HaCat Cells and Neonatal Mice Through MyD88;Drug Design, Development and Therapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3